Lose up to 25% body weight
with Wegovy®*, now with
more options than ever.
†Price includes medication only, if prescribed. An active Hims Weight Loss Membership is required ($39 for the first month, auto-renews at $149/month thereafter). Membership is billed separately and does not include or guarantee a prescription. Medication is not available without a membership. Membership fee is not included.
†Price includes medication only, if prescribed. An active Hims Weight Loss Membership is required ($39 for the first month, auto-renews at $149/month thereafter). Membership is billed separately and does not include or guarantee a prescription. Medication is not available without a membership. Membership fee is not included.
*See source. Wegovy®, Zepbound®, and Foundayo™ are FDA-approved for weight loss. Ozempic® and Mounjaro® are FDA approved for type 2 diabetes and are available only to patients who meet clinical eligibility criteria, as determined by a licensed healthcare provider. Ozempic® and Wegovy® are registered trademarks of Novo Nordisk A/S. Mounjaro®, Zepbound®, and KwikPen® are registered trademarks of Eli Lilly and Company. Foundayo™ is a trademark of Eli Lilly and Company. Hims, Inc. is not affiliated or endorsed by Eli Lilly and Company.
*See source. Wegovy®, Zepbound®, and Foundayo™ are FDA-approved for weight loss. Ozempic® and Mounjaro® are FDA approved for type 2 diabetes and are available only to patients who meet clinical eligibility criteria, as determined by a licensed healthcare provider. Ozempic® and Wegovy® are registered trademarks of Novo Nordisk A/S. Mounjaro®, Zepbound®, and KwikPen® are registered trademarks of Eli Lilly and Company. Foundayo™ is a trademark of Eli Lilly and Company. Hims, Inc. is not affiliated or endorsed by Eli Lilly and Company.
The FDA does not verify the safety, effectiveness, or quality of compounded drugs. Prescription products require an online consultation with a healthcare provider who will determine if a prescription is appropriate. Actual price to customer will depend on product and subscription plan purchased. The featured products include compounded products which have not been approved by the FDA.
The FDA does not verify the safety, effectiveness, or quality of compounded drugs. Prescription products require an online consultation with a healthcare provider who will determine if a prescription is appropriate. Actual price to customer will depend on product and subscription plan purchased. The featured products include compounded products which have not been approved by the FDA.

Compounded drug products are not approved or evaluated for safety, effectiveness, or quality by the FDA. Not available in all 50 states.
Collect your sample at home, ship it back to the lab, see your results.
Connect with a provider and receive a plan and dose built around your labs, if eligible.
Get twice-yearly lab testing to track progress and recalibrate your protocol with your provider as needed.
Compounded drug products are not approved or evaluated for safety, effectiveness, or quality by the FDA. Prescription required.
This test is ordered by a healthcare provider and processed in a CLIA-certified lab. It does not diagnose conditions. Review results with your provider.
Tasso, Tasso+ and the Tasso logo are trademarks of Tasso Inc. Hims, Inc. is not affiliated with or endorsed by Tasso Inc.
Not available in all 50 states. Eligibility determination and prescription required for all lab tests. Lab results alone are not intended to diagnose, treat, or cure any condition. The test for a cancer signal is not FDA approved and not diagnostic, does not detect a signal for all cancers, and false positive and false negative results do occur. Test should be used in addition to healthcare provider recommended screening tests. For more important safety and laboratory/test information, please click here.
Not available in all 50 states. Eligibility determination and prescription required for all lab tests. Lab results alone are not intended to diagnose, treat, or cure any condition. The test for a cancer signal is not FDA approved and not diagnostic, does not detect a signal for all cancers, and false positive and false negative results do occur. Test should be used in addition to healthcare provider recommended screening tests. For more important safety and laboratory/test information, please click here.
Meet the team of leading specialists with decades of combined experience across key specialties.